Peer-reviewedCC BY-NC-ND 4.0Molecular & Cellular Oncology
Targeting ATR/CHK1 pathway in acute myeloid leukemia to overcome chemoresistance
Related
- Targeting PTPN2-mediated dephosphorylation destabilizes c-MYC and suppresses acute myeloid leukemia survival
- Next-Generation Liposomal and Nanoparticle-Based Systems for Glioblastoma: Molecular Targeting Strategies to Overcome the Blood–Brain Barrier
- FDX1 suppresses acute myeloid leukemia progression and reverses cuproptosis resistance via the ROS/p53/ME1 axis
- Targeting circular RNAs to overcome therapeutic resistance in liver cancer: from mechanisms to clinical prospects
- ALKBH8 promotes acute myeloid leukemia progression by coupling codon-dependent translation elongation to mRNA stability
BibTeX
@article{david2026targeting,
title = {{Targeting ATR/CHK1 pathway in acute myeloid leukemia to overcome chemoresistance}},
author = {Laure David and Stephane Manenti and Christian Récher and Jean-Sébastien Hoffmann and Christine Didier},
journal = {Molecular \& Cellular Oncology},
year = {2026},
month = oct,
doi = {10.1080/23723556.2017.1289293},
url = {https://hal.science/hal-05783060v1},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Targeting ATR/CHK1 pathway in acute myeloid leukemia to overcome chemoresistance
AU - Laure David
AU - Stephane Manenti
AU - Christian Récher
AU - Jean-Sébastien Hoffmann
AU - Christine Didier
PY - 2026
DA - 2026/10/07
JO - Molecular & Cellular Oncology
DO - 10.1080/23723556.2017.1289293
UR - https://hal.science/hal-05783060v1
SN - 2372-3556
ER -